Resin substitution is the number every other number in a solid-phase run is derived from. The nominal batch size is calculated from the starting resin substitution and the mass of resin charged, and that batch size in turn fixes the equivalents of amino acid derivative and every reagent charge downstream of it [1]. A wrong substitution value does not announce itself. It produces a synthesis running at a different stoichiometry from the one written on the batch record, and the first evidence is a crude profile that does not match the small-scale run that justified the scale-up.
Measure substitution before you trust it
For Fmoc-substituted resins the standard determination suspends the resin in 20% (v/v) piperidine in DMF and quantifies the dibenzofulvene–piperidine adduct by ultraviolet–visible spectroscopy, conventionally at the adduct's absorption maximum of 301.0 nm [1]. The weak point is the molar absorption coefficient. Reported values for that adduct span roughly 7100 to 8100 L mol−1 cm−1, and choosing one end of that range rather than the other can make nominal batch sizes differ by up to 14% [1]. On a 100 mg screen that discrepancy disappears into the noise of a single manual weighing. On a run where every amino acid charge is computed from the number, a 14% error in the assumed scale is a 14% error in every equivalent, for every cycle. Eissler and colleagues also showed a practical fix for a separate error source in the same determination: measuring at 289.8 nm instead of at the 301.0 nm maximum reduces the impact of wavelength accuracy on the result [1].
The operational consequence is that substitution belongs to the lot in front of you, not to the catalogue entry. Determine it in replicate on the material you are actually charging, and record which coefficient and which wavelength produced the figure.
What loading buys, and what it costs
Throughput argues for the highest loading obtainable. An industrial account of peptide manufacturing states the target directly: aim for the highest loading that does not impede process performance or reduce product quality, ideally above 1 mmol g−1, with a working minimum around 0.30 mmol g−1 [2]. The same review adds that during development it is not uncommon for high loadings to be unachievable because of aggregation or other factors [2]. That pair of statements is the whole tension. Loading is a throughput lever whose ceiling is set by the chemistry of the particular sequence, not by the resin specification.
Loading is also something you set rather than something you accept. 2-Chlorotrityl chloride resin is highly susceptible to moisture, which reduces resin loading and lowers synthetic yields, so activation with thionyl chloride before assembly is recommended. Román and co-workers showed the extent of activation is tunable by reagent charge: 2% SOCl2 in anhydrous dichloromethane gave up to 44% activation of the resin, which they describe as suitable for the synthesis of longer peptides, while 25% SOCl2 gave up to 80% activation, both within a 5 min reaction time [3]. Deliberate partial activation is therefore a down-loading method with a dial on it. The converse also holds: a resin lot that has taken up water on the shelf arrives at the vessel carrying a loading nobody chose.
Why high loading and difficult sequences do not mix
On-resin aggregation is an interchain phenomenon, and its signature is mechanical. Krchnák and colleagues measured the swollen volume of peptidyl-resin after every coupling across 87 sequence-unrelated peptides and found that non-random incomplete acylation of the growing chain is sequence-dependent, is caused by aggregation of the peptide chains, and is manifested by a decreased swelling capacity; from that dataset they derived a per-residue aggregation parameter used to predict potentially difficult sequences [4]. The bed shrinking is not a curiosity alongside the coupling failure. It is the readout of it.
The practical consequence is that reagent stops reaching a fraction of the chains no matter how much of it you add. Coin, Beyermann and Bienert describe reducing aggregation of the growing chain as the central requirement for difficult sequences, aggregation being the main cause of failure in peptide chemosynthesis, and show that backbone-disrupting depsipeptide and pseudoproline units were needed for the Asn15 analogue of the WW domain FBP28, a sequence they state is impossible to obtain with their standard protocol [5]. That same standard Fmoc/tBu protocol on PEG-modified polystyrene delivered the 41-mer corticotropin-releasing factor in approximately 80 working hours [5]. Length alone is not the predictor.
Solubilising tags attack the same problem from the C-terminus. Freiburghaus and colleagues developed a simplified C-terminal hexaarginine tag, removable enzymatically with carboxypeptidase B, and evaluated it across six different solid supports using automated fast-flow synthesis, reporting consistent aggregation suppression and improved crude purities across all resin types examined [6]. What that licenses is a claim about that tag on those supports under fast-flow conditions. It does not tell you the tag will rescue your sequence, and it does not substitute for knowing how your own support behaves.
You can also watch aggregation happen rather than infer it from the final chromatogram. Sletten and co-workers incorporated a pressure-based variable bed flow reactor into an automated synthesiser, which permitted real-time monitoring of resin swelling and used that signal to determine amino acid coupling efficiency and on-resin aggregation during the run [7]. A large batch vessel gives you no equivalent instrument. What it gives you is bed height, drainage behaviour and an analytical result days later.
Mixing and mass transfer when the vessel gets large
Swelling is the transport variable, and loading is one of its determinants. A systematic study of polystyrene and PEG-based resins in greener solvents found that chemical factors — the nature of the functionality and linker, and the degree of loading — had a far larger influence on resin swelling than physical parameters such as bead size, and extended the analysis to the swelling changes seen during deprotection and chain elongation in solid-phase synthesis [8]. Loading therefore acts on mass transfer twice over: it sets how many chains compete for reagent inside a given bead, and it alters how far that bead opens in the first place.
Solvent is not a free variable either. Swelling in binary solvent mixtures was generally found not to vary linearly with the relative amount of each component; Ran and colleagues mapped high, medium and low swelling regions for Merrifield and HypoGel 200 resins in Hansen solubility parameter space and showed that an appropriate mixture of two green solvents was more effective for solid-phase peptide synthesis on Merrifield resin than either solvent used alone [9]. A solvent substitution validated on one gram is a swelling change, and swelling changes are volumetric.
Volume is where scale bites. Reactor volumes up to 1000 litres are common, reactors are often jacketed to allow heating and cooling, and mixing is performed by mechanical agitation rather than by the gas bubbling, shaking or similar means normal at laboratory scale [2]. That substitution is not cosmetic. Bubbling fluidises a shallow bed more or less uniformly; an impeller has to move a dense, swollen, shear-sensitive slurry, and the diffusion path into the interior of a bead is no longer negligible relative to the time the reagent spends well mixed around it. Swelling also constrains how much resin the vessel can hold: the same review records that swelling of ChemMatrix resin was sometimes excessive, which can be problematic from a production perspective because a higher swelling volume limits batch size [2]. Meanwhile the solvent must keep everything in solution while doing this work — building blocks, reagents and by-products are expected to be soluble at 0.25 M or above, and a viscosity nearer that of DMF (0.8 mPa s) may be required to ensure appropriate swelling of the resin and diffusion of reagents into commonly used supports [2].
Reagent excess stops being a rounding error
A conventional cycle runs a substantial excess. Fmoc-amino acid, DIC and Oxyma Pure at 3:3:3 equivalents for one hour is one of the coupling protocols tabulated in that review, alongside protocols using Fmoc-amino acid, HBTU and HOBt at 3.0 equivalents with 6.0 equivalents of DIPEA [2]. At 0.1 mmol that excess is tens of milligrams and nobody costs it. At kilogram scale it becomes the dominant raw material term: a cost analysis of one 39-mer campaign apportioned raw material cost as solvents 27%, resin 15%, coupling reagents 23%, and amino acid building blocks and other reagents the remaining 35% [2].
The excess is a process choice rather than a physical constant. The same review describes an Aib-containing ACP decapeptide assembled in DMSO/ethyl acetate (1:9) using 1.3 equivalents of Fmoc-amino acid and Oxyma Pure and 3.25 equivalents of DIC at 45–50 °C for 30 min, obtained at 76% purity and 84% crude yield [2]. That is one sequence in one solvent system; it establishes that near-stoichiometric coupling is attainable, not that it will hold for your target. The wider position is that the state of the art still runs largely on legacy technology using large amounts of highly hazardous reagents and solvents, and the ACS Green Chemistry Institute Pharmaceutical Roundtable identified the development of greener processes for peptide APIs in 2016 as a critical unmet need [10].
Excess also carries hazards that only register at volume. Erny and colleagues determined that hydrogen cyanide is always formed in amide bond-forming reactions on solid support in DMF when DIC/Oxyma is employed; of the solvents examined, an NBP/ethyl acetate (1:4) mixture gave the lowest rate of HCN formation together with the highest rate of amide bond formation both in solution and on solid support, and dimethyl trisulfide scavenged HCN without inhibiting the rate of amidation [11]. The chemistry is identical at both scales. The quantity of reagent turning over, and therefore the quantity of by-product, is not.
Filtration and wash volume
Washing is where the solvent goes. In the manufacturing account, washing steps carry the biggest negative impact in terms of solvent consumption, and the requirement placed on the wash solvent is that it remain efficient at solubilising by-products and excess reagents so that overall solvent volumes can be minimised [2]. Unlike a laboratory setting, all operations for synthesis — heating, filtering, addition of reagents and solvents, isolation and purification — are time-consuming and present engineering challenges [2]. The reasoning that follows for the chemist is straightforward: the time a bed takes to drain is time the resin-bound peptide spends in contact with the liquor it is supposed to have left, so wash count, wash solvent and drainage rate are variables in the synthesis, not merely in the schedule.
Solvent substitution interacts with this, and the two effects should be judged separately. Replacing DMF with N-butylpyrrolidinone gave a lower or equal level of racemization for the amino acids most prone to it and clearly lower aspartimide formation [12]. That is a side-reaction result. A solvent can improve side-reaction profiles and still change how the bed swells and drains, and only the first of those is what the cited comparison measured.
Heat
Vessels are jacketed because the temperature does not look after itself [2]. Heat is also applied deliberately. A systematic search at elevated temperature using aggregating peptide models identified DIC/HOBt in 25% dimethyl sulfoxide/toluene at 60 °C as the optimised condition for unsulfated cholecystokinin-12, a solvent system found to be compatible with several polymeric supports [13].
Temperature is not free. In microwave-enhanced Fmoc synthesis of a model 20-mer containing all 20 natural amino acids, cysteine, histidine and aspartic acid were susceptible to racemization; lowering the microwave coupling temperature from 80 °C to 50 °C limited racemization of histidine and cysteine, and racemization during the coupling reaction was limited to the activated ester state of the amino acids up to 80 °C [14]. Use of the hindered base collidine minimised formation of D-cysteine, and aspartimide formation with its subsequent aspartate racemization was reduced by adding HOBt to the deprotection solution and/or using piperazine in place of piperidine [14]. A vessel that removes heat poorly reaches local temperatures the small-scale run never sampled, which is why a thermal profile is worth recording on the first scaled batch even when the setpoint is unchanged.
The reagents themselves have thermal limits worth establishing before large charges are made up. Sperry and colleagues assessed 45 peptide coupling reagents in common pharmaceutical manufacturing use by differential scanning calorimetry and accelerating rate calorimetry, and put those flagged as potentially impact-sensitive or potentially explosive through drop hammer and explosivity screening [15]. That is an input to reagent selection rather than a process condition, and it only becomes decision-relevant once the charge is large enough for a thermal event to matter.
The first large run is an experiment
It is worth being precise about what fast chemistry does and does not tell you. In a fully automated flow system, Mijalis and colleagues achieved amide bond formation in 7 seconds and total synthesis times of 40 seconds per amino acid residue, with crude purities and isolated yields comparable to those of standard batch solid-phase synthesis [16]. That places a lower bound on the intrinsic coupling chemistry under continuous high reagent flux through a small packed bed. It does not transfer to a stirred vessel of hundreds of litres, where the rate-limiting steps are reagent delivery, dispersion through a dense slurry, and drainage. The gap between those two regimes is precisely what a first scaled run measures.
So design it as a measurement. Determine the substitution of the lot you are charging rather than importing the number from development [1]. Expect the swelling collapse described above to appear at a different residue once bed depth, agitation and cycle time have all changed, and record bed volume through the run instead of assuming it. Take resin samples at the residues that small-scale work flagged, not only at the end, since the real-time swelling signal described earlier belongs to the flow reactor and not to a batch vessel [7]. And treat the loading itself as provisional: if the crude profile degrades where the small-scale synthesis was clean, the aggregation ceiling on loading has been found, and the correct response is to lower it and lose throughput rather than to add equivalents and lose the batch.